C
CheckMate Investigators
Researcher at University of Texas MD Anderson Cancer Center
Publications - 2
Citations - 541
CheckMate Investigators is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Nivolumab & Survival rate. The author has an hindex of 2, co-authored 2 publications receiving 326 citations.
Papers
More filters
Journal ArticleDOI
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
Robert J. Motzer,Brian I. Rini,David F. McDermott,Osvaldo Arén Frontera,Hans J. Hammers,Michael A. Carducci,Pamela Salman,Bernard Escudier,Benoit Beuselinck,Asim Amin,Camillo Porta,Saby George,Victoria Neiman,Sergio Bracarda,Scott S. Tykodi,Philippe Barthélémy,Raya Leibowitz-Amit,Elizabeth R. Plimack,Sjoukje F. Oosting,Bruce G. Redman,Bohuslav Melichar,Thomas Powles,Paul Nathan,Stéphane Oudard,David Pook,Toni K. Choueiri,Frede Donskov,Marc-Oliver Grimm,Howard Gurney,Daniel Y.C. Heng,Christian Kollmannsberger,Michael R. Harrison,Yoshihiko Tomita,Ignacio Duran,Viktor Grünwald,M. Brent McHenry,Sabeen Mekan,Nizar M. Tannir,CheckMate Investigators +38 more
TL;DR: Results showed that nivolumab plus ipilimumab continued to be superior to sunitinib in terms of overall survival and characterisation of response, and safety after extended follow-up in intermediate-risk or poor-risk patients.
Journal ArticleDOI
CheckMate 025: a randomized, open-label, phase Ill study of nivolumab versus everolimus in advanced renal cell carcinoma (RCC)
Robert J. Motzer,Bernard Escudier,David F. McDermott,Saby George,Hans J. Hammers,Sandhya Srinivas,Scott S. Tykodi,Scott S. Tykodi,Jeffrey A. Sosman,Giuseppe Procopio,Elizabeth R. Plimack,Daniel Castellano,Howard Gurney,Frede Donskov,Petri Bono,John Wagstaff,Thomas Gauler,Takeshi Ueda,Li-an Xu,Ian M. Waxman,Padmanee Sharma,CheckMate Investigators +21 more